oxymetazoline nasal short-term
Selected indexed studies
- Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use. (Pediatrics, 2021) [PMID:34607935]
- Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. (Am J Rhinol Allergy, 2013) [PMID:23562197]
- Pharmacologic Agents Used in the Assessment or Correction of Blepharoptosis: A Report by the American Academy of Ophthalmology. (Ophthalmology, 2025) [PMID:40172501]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use. (2021) pubmed
- Pharmacologic Agents Used in the Assessment or Correction of Blepharoptosis: A Report by the American Academy of Ophthalmology. (2025) pubmed
- Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. (2013) pubmed
- Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. (1999) pubmed
- Revisiting Rhinitis Medicamentosa: Examining the Evidence on Topical Nasal Decongestants. (2026) pubmed
- Rhinoscleroma in a 9-year old boy: Rare case report. (2023) pubmed
- Nasal decongestants in monotherapy for the common cold. (2016) pubmed
- Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. (2004) pubmed
- Rebound hypertension following prolonged oxymetazoline use: a signal-generating case report. (2026) pubmed
- Studies of spontaneous fluctuations in congestion and nasal mucosal microcirculation and the effects of oxymetazoline using rhinostereometry and micromanipulator guided laser Doppler flowmetry. (1999) pubmed